SAN DIEGO, Jan. 7, 2026 /PRNewswire/ -- Aspen Neuroscience, Inc., a clinical‑stage biotechnology company pioneering autologous regenerative therapies, today announced two executive leadership appointments: Revati Shreeniwas, M.D., FCCP has joined Aspen as Chief Medical Officer (CMO), and...
Hence then, the article about aspen neuroscience appoints chief commercial officer lisa johnson pratt m d and welcomes revati shreeniwas m d fccp as chief medical officer to accelerate late stage development and commercial readiness was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Aspen Neuroscience Appoints Chief Commercial Officer Lisa Johnson-Pratt, M.D. and Welcomes Revati Shreeniwas, M.D., FCCP as Chief Medical Officer to Accelerate Late‑Stage Development and Commercial Readiness )
Also on site :
- Seizure of Russian-flagged oil tanker: what we know so far
- Fatal I-55 crash shuts down lanes in southwest suburbs; ‘major' traffic backups expected
- Nestlé pulls baby milk batches amid safety fears